PubRank

Marc J Claeys

Author PubWeight™ 41.49‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 2013 9.54
2 Cyclosporine before PCI in Patients with Acute Myocardial Infarction. N Engl J Med 2015 5.90
3 Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med 2005 5.28
4 High-dose folic acid pretreatment blunts cardiac dysfunction during ischemia coupled to maintenance of high-energy phosphates and reduces postreperfusion injury. Circulation 2008 2.47
5 Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial. J Am Coll Cardiol 2010 2.00
6 Flow-mediated vasodilation: a diagnostic instrument, or an experimental tool? Chest 2005 1.78
7 Systemic inflammation and reperfusion injury in patients with acute myocardial infarction. Mediators Inflamm 2005 1.04
8 Effect of folic acid on endothelial function following acute myocardial infarction. Am J Cardiol 2006 0.96
9 Mechanisms and potential therapeutic targets for folic acid in cardiovascular disease. Am J Physiol Heart Circ Physiol 2008 0.95
10 Gender, TIMI risk score and in-hospital mortality in STEMI patients undergoing primary PCI: results from the Belgian STEMI registry. EuroIntervention 2014 0.86
11 Comparison of magnetic resonance imaging of aortic valve stenosis and aortic root to multimodality imaging for selection of transcatheter aortic valve implantation candidates. Am J Cardiol 2011 0.84
12 Depressed expression of MuRF1 and MAFbx in areas remote of recent myocardial infarction: a mechanism contributing to myocardial remodeling? Basic Res Cardiol 2009 0.84
13 Cost-effectiveness of contemporary vascular closure devices for the prevention of vascular complications after percutaneous coronary interventions in an all-comers PCI population. EuroIntervention 2014 0.83
14 Reperfusion therapy and mortality in octogenarian STEMI patients: results from the Belgian STEMI registry. Clin Res Cardiol 2013 0.83
15 Quantitative coronary arteriography on digital flat-panel system. Catheter Cardiovasc Interv 2004 0.81
16 B-type natriuretic peptide and assessment of jeopardised myocardium in acute myocardial infarction. Int J Cardiol 2006 0.79
17 Clinical relevance of clopidogrel unresponsiveness during elective coronary stenting: experience with the point-of-care platelet function assay-100 C/ADP. Am Heart J 2010 0.79
18 Alternative access in transcatheter aortic valve implantation: brachiocephalic artery access. Innovations (Phila) 2012 0.78
19 Donor B-type natriuretic peptide predicts early cardiac performance after heart transplantation. J Heart Lung Transplant 2012 0.78
20 Renal dysfunction in STEMI-patients undergoing primary angioplasty: higher prevalence but equal prognostic impact in female patients; an observational cohort study from the Belgian STEMI registry. BMC Nephrol 2013 0.77
21 Environmental triggers of acute myocardial infarction: results of a nationwide multiple-factorial population study. Acta Cardiol 2015 0.77
22 Transesophageal echocardiography for cardiac thromboembolic risk assessment in patients with severe, symptomatic aortic valve stenosis referred for potential transcatheter aortic valve implantation. Am J Cardiol 2013 0.77
23 Projected inhibition of platelet aggregation with ticagrelor twice daily vs. clopidogrel once daily based on patient adherence data (the TWICE project). Br J Clin Pharmacol 2014 0.77
24 Percutaneous mitral valve repair in high-risk patients: initial experience with the Mitraclip system in Belgium. Acta Cardiol 2014 0.76
25 Effect of ticagrelor on the outcomes of patients with prior coronary artery bypass graft surgery: insights from the PLATelet inhibition and patient outcomes (PLATO) trial. Am Heart J 2013 0.76
26 Influence of ionic and non-ionic radiographic contrast media on leukocyte adhesion molecules. Mediators Inflamm 2003 0.75
27 Mechanism of Symptomatic Improvement After Percutaneous Therapy for Secondary Mitral Regurgitation: Resting and Exercise Hemodynamics. J Am Coll Cardiol 2016 0.75
28 Ummary 2013 ESC guidelines. Acta Cardiol 2014 0.75
29 The determinants of B-type natriuretic peptide release in acute, non-ST-segment elevation myocardial infarction. Acta Cardiol 2011 0.75
30 Comparison of turbidimetric aggregation and in vitro bleeding time (PFA-100) for monitoring the platelet inhibitory profile of antiplatelet agents in patients undergoing stent implantation. Thromb Res 2003 0.75
31 Summary 2015 ESC guidelines. Acta Cardiol 2016 0.75
32 Summary 2014 ESC guidelines. Acta Cardiol 2015 0.75
33 TIMI risk score underestimates prognosis in unstable angina/non-ST segment elevation myocardial infarction. Acute Card Care 2008 0.75
34 Outcome and causes of renal deterioration evaluated by serial cystatin C measurements in acute coronary syndrome patients -- results from the PLATelet inhibition and patient Outcomes (PLATO) study. Am Heart J 2012 0.75
35 Pre-hospital management of acute coronary syndrome patients in Belgium and Luxembourg and other Western European countries. Acta Cardiol 2016 0.75
36 Difference in clinical target lesion revascularization between a silicon carbide-coated and an uncoated thin strut bare-metal stent: the PRO-Vision study. Can J Cardiol 2013 0.75
37 Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial. EuroIntervention 2014 0.75